Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Biocon Ltd.
Swot
Biocon Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Biocon Ltd. has 20 Strengths, 4 Weaknesses, 5 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(20)
Weakness
(4)
Opportunity
(5)
Threats
(3)
Others
(5)
Relative Outperformance versus Industry over 1 Year
Benjamin Graham Value Screen
Price crossing above SMA20 today, and greater than SMA5
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Companies with Zero Promoter Pledge
Negative to Positive growth in Sales and Profit with Strong Price momentum
Top Gainers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
PE higher than Industry PE
High PE (PE > 40)
Major fall in TTM Net Profit
Increasing Trend in Non-Core Income
Broker price or reco upgrades in last month
Brokers upgraded recommendation or target price in the past three months
Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month
FII / FPI or Institutions increasing their shareholding
Broker price or reco upgrades in last month
Broker downgrades in price or recommendation in the past one month
MFs decreased their shareholding last quarter
US FDA Warning Letter
Stocks with improving cash flow, with good durability
Rising Delivery Percentage Compared to Prev Day
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
